{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:58:19Z","timestamp":1791079099155,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT095515"],"award-info":[{"award-number":["WT095515"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT107064"],"award-info":[{"award-number":["WT107064"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.gde.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T06:22:28Z","timestamp":1519280548000},"page":"60-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Genetic syndromes of severe insulin resistance"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7512-7039","authenticated-orcid":false,"given":"A","family":"Melvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"O\u2019Rahilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DB","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2018.02.002_bib0360","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1464-5491.2002.00745.x","article-title":"The assessment of insulin resistance in man","volume":"19","author":"Wallace","year":"2002","journal-title":"Diab Med"},{"key":"10.1016\/j.gde.2018.02.002_bib0365","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2337\/diab.12.3.197","article-title":"Excessive insulin response to glucose in obese subjects as measured by immunochemical assay","volume":"12","author":"Karam","year":"1963","journal-title":"Diabetes"},{"key":"10.1016\/j.gde.2018.02.002_bib0370","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.gde.2018.02.002_bib0375","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2006.12.004","article-title":"Obesity and the skin: skin physiology and skin manifestations of obesity","volume":"56","author":"Yosipovitch","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.gde.2018.02.002_bib0380","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10238-009-0086-5","article-title":"The metabolic profile in patients with skin tags","volume":"10","author":"Sari","year":"2010","journal-title":"Clin Exp Med"},{"issue":"6 Suppl.","key":"10.1016\/j.gde.2018.02.002_bib0385","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1111\/1523-1747.ep12462293","article-title":"Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans","volume":"98","author":"Cruz","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.gde.2018.02.002_bib0390","doi-asserted-by":"crossref","first-page":"72","DOI":"10.7861\/clinmedicine.15-6-s72","article-title":"Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance","volume":"15","author":"Barber","year":"2015","journal-title":"Clin Med"},{"key":"10.1016\/j.gde.2018.02.002_sbref0395","first-page":"1789","article-title":"Insulin resistance masquerading as ovarian hyperthecosis","volume":"102","author":"Brown","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_bib0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.gde.2018.02.002_bib0405","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_sbref0410","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.molmed.2015.04.004","article-title":"The genetics of lipid storage and human lipodystrophies","volume":"21","author":"Robbins","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.gde.2018.02.002_bib0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/79111","article-title":"Failure of adipocyte differentiation causes type II diabetes mellitus?","volume":"26","author":"Danforth","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0420","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2014an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.gde.2018.02.002_bib0425","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gde.2018.02.002_bib0430","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy","volume":"88","author":"Agarwal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_bib0435","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli\u2013Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magre","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0440","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","article-title":"Type 1 familial partial lipodystrophy: understanding the Kobberling syndrome","volume":"54","author":"Guillin-Amarelle","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.gde.2018.02.002_bib0445","first-page":"170","article-title":"Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan Variety)","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_bib0450","first-page":"408","article-title":"A novel heterozygous mutation in the peroxisome proliferator-activated receptor gamma gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_bib0455","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator activated receptor gamma","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.gde.2018.02.002_bib0460","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","author":"Misra","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gde.2018.02.002_bib0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalities in acquired lipodystrophy revisited","volume":"94","author":"Savage","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_bib0470","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gde.2018.02.002_bib0475","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(54)80113-2","article-title":"Leprechaunism: a euphemism for a rare familial disorder","volume":"45","author":"Donohue","year":"1954","journal-title":"J Pediatr"},{"key":"10.1016\/j.gde.2018.02.002_bib0480","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ajcp\/26.3.283","article-title":"Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus; report of 3 cases","volume":"26","author":"Rabson","year":"1956","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.gde.2018.02.002_bib0485","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (Type A and Rabson\u2013Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gde.2018.02.002_bib0490","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (Type B insulin resistance); a 28 year perspective","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gde.2018.02.002_bib0495","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gde.2018.02.002_bib0500","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1172\/JCI117633","article-title":"Interactions between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans","volume":"95","author":"Lewis","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gde.2018.02.002_bib0505","doi-asserted-by":"crossref","DOI":"10.2337\/dc07-2194","article-title":"Plasma adiponectin as a marker of insulin receptor dysfunction","volume":"31","author":"Semple","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.gde.2018.02.002_bib0510","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1534-5807(02)00199-5","article-title":"Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance","volume":"3","author":"Bl\u00fcher","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.gde.2018.02.002_bib0515","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrendo.2010.210","article-title":"Alstrom syndrome: insights into the pathogenesis of metabolic disorders","volume":"7","author":"Girard","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.gde.2018.02.002_bib0520","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ng.2670","article-title":"An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy","volume":"45","author":"Weedon","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0525","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diacare.22.12.2094","article-title":"All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes","volume":"22","author":"Yamada","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.gde.2018.02.002_bib0530","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.gde.2018.02.002_bib0535","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2337\/db13-0949","article-title":"Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity","volume":"63","author":"Dimas","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.gde.2018.02.002_bib0540","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.2274","article-title":"A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance","volume":"44","author":"Manning","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0545","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.2385","article-title":"Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways","volume":"44","author":"Scott","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0550","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.2337\/db14-0319","article-title":"Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity","volume":"63","author":"Scott","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.gde.2018.02.002_sbref0555","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0560","first-page":"106","article-title":"Uber den fetthals (diffuses lipom des halses)","author":"Madelung","year":"1888","journal-title":"Arch Klin Chir"},{"key":"10.1016\/j.gde.2018.02.002_bib0565","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/aps.2011.153","article-title":"Rare adipose disorders (RADs) masquerading as obesity","volume":"33","author":"Herbst","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.gde.2018.02.002_bib0570","first-page":"551","article-title":"Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A\u2192G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome","volume":"52","author":"Holme","year":"1993","journal-title":"Am J Human Genet"},{"key":"10.1016\/j.gde.2018.02.002_sbref0575","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/hmg\/ddv229","article-title":"Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy","volume":"24","author":"Sawyer","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0580","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archneurol.2009.284","article-title":"Genotype-phenotype correlations in Charcot\u2013Marie-Tooth disease type 2 caused by mitofusin 2 mutations","volume":"66","author":"Calvo","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gde.2018.02.002_bib0585","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1083\/jcb.200211046","article-title":"Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development","volume":"160","author":"Chen","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.gde.2018.02.002_sbref0590","first-page":"6","article-title":"Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression","author":"Rocha","year":"2017","journal-title":"Elife"},{"issue":"Pt 5","key":"10.1016\/j.gde.2018.02.002_bib0595","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1042\/BST0340647","article-title":"Signalling through Class I PI3Ks in mammalian cells","volume":"34","author":"Hawkins","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.gde.2018.02.002_bib0600","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","article-title":"SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling","volume":"93","author":"Chudasama","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0605","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0610","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","article-title":"Mutations in PIK3R1 cause SHORT syndrome","volume":"93","author":"Dyment","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2018.02.002_sbref0615","doi-asserted-by":"crossref","first-page":"e88766","DOI":"10.1172\/jci.insight.88766","article-title":"Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations","volume":"1","author":"Huang-Doran","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.gde.2018.02.002_bib0620","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1073\/pnas.0900909106","article-title":"A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia","volume":"106","author":"Dash","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2018.02.002_bib0625","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature13425","article-title":"A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes","volume":"512","author":"Moltke","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.gde.2018.02.002_bib0630","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0635","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1210\/jc.2009-1824","article-title":"Higher adiponectin levels in patients with Berardinelli\u2013Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency","volume":"95","author":"Antuna-Puente","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_bib0640","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli\u2013Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_bib0645","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gde.2018.02.002_bib0650","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.23.2.120","article-title":"Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state","volume":"23","author":"Kopperling","year":"1986","journal-title":"J Med Genetics"},{"key":"10.1016\/j.gde.2018.02.002_bib0655","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genetics"},{"key":"10.1016\/j.gde.2018.02.002_bib0660","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gde.2018.02.002_bib0665","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","article-title":"Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC","volume":"1","author":"Rubio-Cabezas","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.gde.2018.02.002_bib0670","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.gde.2018.02.002_bib0675","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.1073\/pnas.1408523111","article-title":"Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease","volume":"111","author":"Payne","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2018.02.002_bib0680","doi-asserted-by":"crossref","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (Type A and Rabson\u2013Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gde.2018.02.002_bib0685","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gde.2018.02.002_bib0690","doi-asserted-by":"crossref","first-page":"E192","DOI":"10.1210\/jc.2010-0419","article-title":"A novel syndrome of mandibular hypoplasia, deafness, and progeroid features associated with lipodystrophy, undescended testes, and male hypogonadism","volume":"95","author":"Shastry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gde.2018.02.002_bib0695","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.272.5259.258","article-title":"Positional cloning of the Werner's syndrome gene","volume":"272","author":"Yu","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.gde.2018.02.002_bib0700","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng867","article-title":"Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome","volume":"31","author":"Collin","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0705","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/hmg\/5.Supplement_1.1457","article-title":"Molecular genetics of Bloom's syndrome","volume":"5 Spec No","author":"Ellis","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2018.02.002_bib0710","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/341908","article-title":"Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C","volume":"71","author":"Novelli","year":"2002","journal-title":"Am J Hum Genet"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X18300030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X18300030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:55:35Z","timestamp":1760702135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X18300030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":71,"alternative-id":["S0959437X18300030"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2018.02.002","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic syndromes of severe insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}